Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapy
Satyen H. Gohil(Broad Institute), Kenneth J. Livak(Broad Institute), Derin B. Keskin(Dana-Farber Cancer Institute), J. Bryan Iorgulescu(Broad Institute), David A. Braun(Yale Cancer Center)
Cited by 286
Related Papers
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
|Nature|2018|1.4k
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
|Nature Medicine|2020|1k
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
|Cancer Cell|2021|624
A large peptidome dataset improves HLA class I epitope prediction across most of the human population
|Nature Biotechnology|2019|539
Progressive immune dysfunction with advancing disease stage in renal cell carcinoma
|Cancer Cell|2021|515